🔬 Answering the toughest question in a projected $5.6 trillion industry

NVIDIA CEO calls this field “the next amazing revolution” Recently launched   Hey {NAME}, Jensen Huang, CEO of $2.5 trillion chip leader NVIDIA, recently talked about the promise of this field: “Where do I think the next amazing revolution is going to come? And this is going to be flat out one of the biggest ones ever… There’s no question that digital biology is going to be it.” That’s why [this digital biology startup](~/AAQRxQA~/RgRolev4P0S0aHR0cHM6Ly9yZXB1YmxpYy5jb20vc3ludGVuc29yP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPUxhdW5jaCZ1dG1fY29udGVudD0zY2Y3Y2I4Yy1hM2FlLTQ2NjktODc2Mi0wMDBjZjVkOTFmZjJfYWxsJnV0bV90ZXJtPXN5bnRlbnNvciZsaWQ9Z2w5emx6MXhqZHk4VwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~) is already attacking the most challenging question in drug development: “Is this treatment going to work?” Clinical trials fail 90% of the time. Companies can spend up to $2B bringing a new drug to market. Even then, most drugs are only effective in 30 to 50 percent of people. In fact, adverse drug reactions are the fourth leading cause of death in America. A better solution for drug development holds the potential to save billions of dollars and millions of lives. [This young startup](~/AAQRxQA~/RgRolev4P0S0aHR0cHM6Ly9yZXB1YmxpYy5jb20vc3ludGVuc29yP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPUxhdW5jaCZ1dG1fY29udGVudD0zY2Y3Y2I4Yy1hM2FlLTQ2NjktODc2Mi0wMDBjZjVkOTFmZjJfYWxsJnV0bV90ZXJtPXN5bnRlbnNvciZsaWQ9cnQ5aDRtdm5wdnEwVwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~) is answering that key question in a distinctive way. Instead of just looking at what the drug will do to the body, [this company’s innovative method](~/AAQRxQA~/RgRolev4P0S0aHR0cHM6Ly9yZXB1YmxpYy5jb20vc3ludGVuc29yP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPUxhdW5jaCZ1dG1fY29udGVudD0zY2Y3Y2I4Yy1hM2FlLTQ2NjktODc2Mi0wMDBjZjVkOTFmZjJfYWxsJnV0bV90ZXJtPXN5bnRlbnNvciZsaWQ9dXZnems1ODV0eXZoVwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~)~/AAQRxQA~/RgRolev4P0S0aHR0cHM6Ly9yZXB1YmxpYy5jb20vc3ludGVuc29yP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPUxhdW5jaCZ1dG1fY29udGVudD0zY2Y3Y2I4Yy1hM2FlLTQ2NjktODc2Mi0wMDBjZjVkOTFmZjJfYWxsJnV0bV90ZXJtPXN5bnRlbnNvciZsaWQ9NzA4Zzd3eTRtZmtiVwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~~/AAQRxQA~/RgRolev4P0S0aHR0cHM6Ly9yZXB1YmxpYy5jb20vc3ludGVuc29yP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPUxhdW5jaCZ1dG1fY29udGVudD0zY2Y3Y2I4Yy1hM2FlLTQ2NjktODc2Mi0wMDBjZjVkOTFmZjJfYWxsJnV0bV90ZXJtPXN5bnRlbnNvciZsaWQ9dTZxaThvMmRiamI3VwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~ also looks at how the body interacts with the drug, creating AI-based simulations down to the cellular and tissue level. Their approach is designed to better predict side effects and toxicity—the key causes of clinical trial failure—before the trials start. The potential benefits are significant – fewer clinical trial failures, a faster drug discovery process, and major cost savings. Delivering on those improvements could prove potentially valuable in an industry projected to reach $5.6 trillion within 10 years. See how they are attacking the problem, [right here.](~/AAQRxQA~/RgRolev4P0S0aHR0cHM6Ly9yZXB1YmxpYy5jb20vc3ludGVuc29yP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPUxhdW5jaCZ1dG1fY29udGVudD0zY2Y3Y2I4Yy1hM2FlLTQ2NjktODc2Mi0wMDBjZjVkOTFmZjJfYWxsJnV0bV90ZXJtPXN5bnRlbnNvciZsaWQ9cGlpMmhja2Q4bHF3VwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~) ~/AAQRxQA~/RgRolev4P0S0aHR0cHM6Ly9yZXB1YmxpYy5jb20vc3ludGVuc29yP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPUxhdW5jaCZ1dG1fY29udGVudD0zY2Y3Y2I4Yy1hM2FlLTQ2NjktODc2Mi0wMDBjZjVkOTFmZjJfYWxsJnV0bV90ZXJtPXN5bnRlbnNvciZsaWQ9bDBtc2oycDJ4ZWNwVwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~ Trusted leadership Experts from DeepMind, Novartis, GSK, and Stanford.   Key partnerships Collaborations with Stanford, University of Michigan, MILA   Early progress Working with multiple firms with ~$50B in AUM   [View Company on Republic](~/AAQRxQA~/RgRolev4P0S0aHR0cHM6Ly9yZXB1YmxpYy5jb20vc3ludGVuc29yP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPUxhdW5jaCZ1dG1fY29udGVudD0zY2Y3Y2I4Yy1hM2FlLTQ2NjktODc2Mi0wMDBjZjVkOTFmZjJfYWxsJnV0bV90ZXJtPXN5bnRlbnNvciZsaWQ9MDg5b2Zkd3hwamxtVwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~)   [Instagram](~/AAQRxQA~/RgRolev4P0Q-aHR0cHM6Ly93d3cuaW5zdGFncmFtLmNvbS9qb2lucmVwdWJsaWMvP2hsPWVuJmxpZD00eGhwOTBjOHNvZzRXA3NwY0IKZqv4ZrNmvyEF0lIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO) [LinkedIn](~/AAQRxQA~/RgRolev4P0RHaHR0cHM6Ly93d3cubGlua2VkaW4uY29tL2NvbXBhbnkvcmVwdWJsaWMuY28vbXljb21wYW55P2xpZD1pNnoxazYxaDZ5YzJXA3NwY0IKZqv4ZrNmvyEF0lIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO) [Twitter](~/AAQRxQA~/RgRolev4P0QxaHR0cHM6Ly90d2l0dGVyLmNvbS9qb2lucmVwdWJsaWM_bGlkPTA4ZXhqNHk2YWgwZVcDc3BjQgpmq_hms2a_IQXSUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~) [YouTube](~/AAQRxQA~/RgRolev4P0RJaHR0cHM6Ly93d3cueW91dHViZS5jb20vY2hhbm5lbC9VQ21QdUNNbzhmVk50cTRJeHdPX291V0E_bGlkPXU2NmlzeG5id2pnalcDc3BjQgpmq_hms2a_IQXSUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~) ~/AAQRxQA~/RgRolev4P0RXaHR0cHM6Ly9hcHBzLmFwcGxlLmNvbS91cy9hcHAvcmVwdWJsaWMtaW52ZXN0LWluLXN0YXJ0dXBzL2lkMTQ3NTIzMDAyMj9saWQ9OXBwZGNncm05ZXZjVwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~ ~/AAQRxQA~/RgRolev4P0RaaHR0cHM6Ly9wbGF5Lmdvb2dsZS5jb20vc3RvcmUvYXBwcy9kZXRhaWxzP2lkPWNvbS5yZXB1YmxpY21vYmlsZSZobD1lbl9VUyZsaWQ9MDFvbDJtMDBic2syVwNzcGNCCmar-GazZr8hBdJSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~   Private equity investing could be risky—learn more. This email was sent by Republic. Crowdfunding investments can result in total loss, and may be impossible to resell. Read about risks. Republic Core LLC ("Core") provides technology and support services to OpenDeal Inc. and its affiliates (collectively, the "Republic Ecosystem"). Republic Note holders and as well as users of the site and services maintained by the Republic Ecosystem, regardless of and their activities on or relating to the Republic Ecosystem, are subject to the applicable terms of service, in their entirety. Core cannot give investment advice, analysis or recommendations with respect to any securities, and is not a registered broker-dealer, funding portal or investment adviser. Securities offerings displayed by Core may be facilitated by its affiliates in the Republic Ecosystem, OpenDeal Portal LLC d/b/a Republic, or OpenDeal Broker LLC d/b/a The CapitalR, Republic Capital Adviser LLC, Republic Deal Room Advisor LLC, Fig Publishing, Inc. or by a third-party issuer. This email is intended only for accredited investors with a pre-existing relationship with the Republic Ecosystem. Please notify the sender immediately if you have received this email by mistake, then delete it. Private investments are risky and illiquid, never invest more than you can afford to lose, consult with your trusted advisors and do your own diligence before investing. This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed; they do not constitute legal or investment advice. Please notify the sender immediately if you have received this e-mail by mistake, then delete it. No longer interested in new offering launch emails? Adjust your [notification settings](~/AAQRxQA~/RgRolev4P0QraHR0cHM6Ly9yZXB1YmxpYy5jb20vc2V0dGluZ3Mvbm90aWZpY2F0aW9uc1cDc3BjQgpmq_hms2a_IQXSUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~). [Unsubscribe from all emails](~/AAQRxQA~/RgRolev4P4QTAmh0dHBzOi8vMDUuZW1haWxpbmJvdW5kcHJvY2Vzc2luZy5jb20vZW5jX3VzZXIvdW5zdWJzY3JpYmU_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_hms2a_IQXSUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~) 149 E 23rd St #2001, New York, NY 10010